What is the growth forecast for the Medical Imaging Technologies market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Medical Imaging Technologies for Oncology Diagnostics market?

Advances in technology and increasing cancer incidence are key drivers of the market.

Which regions are leaders in the Medical Imaging Technologies for Oncology Diagnostics market?

North America and Europe are the leading regions in the market.

Who are the top companies in the Medical Imaging Technologies for Oncology Diagnostics market?

Top companies include GE Healthcare, Siemens Healthineers, and Philips Healthcare.

What future opportunities exist in the Medical Imaging Technologies for Oncology Diagnostics market?

Emerging markets and advancements in AI technology present future opportunities.

How will technology impact the Medical Imaging Technologies for Oncology Diagnostics market?

Advances in technology will improve diagnostic accuracy and patient outcomes.

What is the current regulatory landscape for the Medical Imaging Technologies market?

Stringent regulations and standards govern the market, ensuring safety and efficacy.

How Big Is the Medical Imaging Technologies for Oncology Diagnostics Market? Size, Share & Forecast 2033

Medical Imaging Technologies for Oncology Diagnostics by Application (Hospitals, Doctor's Offices, Freestanding Clinics, Equipment Leasing Companies, Other), by Types (X-Ray, Magnetic Resonance Imaging (MRI), Nuclear Imaging, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Medical Imaging Technologies for Oncology Diagnostics Market Size | CAGR 10.2 Forecast 2033

How Big Is the Medical Imaging Technologies for Oncology Diagnostics Market? Size, Share & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Medical Imaging Technologies for Oncology Diagnostics Market Overview

The Medical Imaging Technologies for Oncology Diagnostics market refers to the use of advanced imaging technologies for the diagnosis and treatment of cancer. As the global healthcare industry continues to evolve, the Medical Imaging Technologies for Oncology Diagnostics market size is expected to reach $13.4 billion by 2026, with a growth outlook that is largely driven by the increasing incidence of cancer and the need for early diagnosis. The market forecast indicates a compound annual growth rate (CAGR) of 7.3% from 2026 to 2033, with the industry expansion being driven by technological advancements, regulatory approvals, and changing consumer behavior. The scope of the market encompasses various imaging modalities, including magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET).

Loading chart…

The key forces shaping the Medical Imaging Technologies for Oncology Diagnostics industry include technological shifts, such as the adoption of artificial intelligence (AI) and machine learning (ML), regulatory approvals, and changing consumer behavior. The largest region in the market is North America, while the fastest-growing region is Asia-Pacific. The growth forecast is driven by macro drivers such as the increasing incidence of cancer, the need for early diagnosis, and the rising demand for advanced imaging technologies. Overall, the Medical Imaging Technologies for Oncology Diagnostics market is expected to experience significant growth over the forecast period, driven by the increasing adoption of advanced imaging technologies and the need for early cancer diagnosis.

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	2.68 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare; Siemens Healthcare; Philips Healthcare; Advanced Medical; Agfa Healthcare; Carestream Health; McKesson; Techniscan Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Medical Imaging Technologies for Oncology Diagnostics market is poised for significant growth, driven by advancements in technology and increasing demand for accurate diagnostics. The Medical Imaging Technologies for Oncology Diagnostics market size is expected to expand substantially, with a growth forecast that indicates a promising future for industry stakeholders.

Growth Drivers2 items

Advances in artificial intelligence and machine learning are enhancing the capabilities of medical imaging technologies, enabling more accurate and efficient oncology diagnostics. This is driving adoption and contributing to the growth of the Medical Imaging Technologies for Oncology Diagnostics market.

The increasing prevalence of cancer and the need for early detection are fueling demand for medical imaging technologies, thereby influencing the Medical Imaging Technologies for Oncology Diagnostics market size and growth forecast.

Restraints2 items

High costs associated with the development and implementation of advanced medical imaging technologies are limiting their adoption in some regions, posing a restraint to the growth of the Medical Imaging Technologies for Oncology Diagnostics market.

Stringent regulatory requirements and the need for compliance with standards such as HIPAA are challenging for manufacturers, potentially slowing the pace of innovation and impacting the Medical Imaging Technologies for Oncology Diagnostics market size.

Opportunities2 items

Emerging economies present significant opportunities for the expansion of the Medical Imaging Technologies for Oncology Diagnostics market, driven by increasing healthcare expenditures and a growing need for advanced diagnostic technologies.

The integration of cloud computing and internet of medical things (IoMT) in medical imaging technologies offers opportunities for enhanced data management, analysis, and sharing, further driving the growth forecast of the Medical Imaging Technologies for Oncology Diagnostics market.

Challenges2 items

Ensuring data privacy and security in the context of medical imaging technologies for oncology diagnostics is a significant challenge, given the sensitive nature of patient information and the need to comply with regulatory standards.

The shortage of skilled professionals who can effectively operate and interpret the results from advanced medical imaging technologies poses a challenge to the widespread adoption and effective utilization of these technologies in oncology diagnostics, affecting the Medical Imaging Technologies for Oncology Diagnostics market size.

Market Segmentation

Loading chart…

The Application segment of the Medical Imaging Technologies for Oncology Diagnostics market refers to the various uses of imaging technologies in cancer diagnosis and treatment. This segment is crucial in understanding the Medical Imaging Technologies for Oncology Diagnostics segmentation and its impact on the overall market size. The application segment includes subtypes such as diagnosis, treatment planning, and patient monitoring, each contributing to the market's growth.

The Types segment of the Medical Imaging Technologies for Oncology Diagnostics market encompasses various imaging modalities used in cancer diagnosis. This segment is vital in understanding the market taxonomy and its contribution to the overall market size. The types segment includes subtypes such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and ultrasound, each with its unique applications and advantages in oncology diagnostics.

Medical Imaging Technologies for Oncology Diagnostics Segmentation Breakdown11 items

Application

Hospitals

Doctor's Offices

Freestanding Clinics

Equipment Leasing Companies

Other

Types

X-Ray

Magnetic Resonance Imaging (MRI)

Nuclear Imaging

Other

Regional Insights

Loading chart…

The Medical Imaging Technologies for Oncology Diagnostics market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced medical imaging technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: for North America, demographics and ecosystem maturity; for Europe, regional forecast and infrastructure; for Asia Pacific, investments and adoption; for Latin America, policies and demographics; and for Middle East & Africa, infrastructure and ecosystem maturity.

Regional Insights5 items

North America: largest region, driven by demographics and ecosystem maturity

Europe: steady growth, driven by regional forecast and infrastructure

Asia Pacific: fastest-growing region, driven by investments and adoption

Latin America: moderate growth, driven by policies and demographics

Middle East & Africa: slow growth, driven by infrastructure and ecosystem maturity

Competitive Landscape

The Medical Imaging Technologies for Oncology Diagnostics competitive landscape is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, product innovation, and regulatory approvals. The market is driven by the need for accurate and efficient diagnostic solutions, with key players focusing on developing innovative products and services to differentiate themselves. The Medical Imaging Technologies for Oncology Diagnostics competitive landscape is characterized by high competition, with companies employing various strategies to gain market share.

Companies in this market are adopting strategies such as M&A, partnerships, and product launches to expand their offerings and reach. Competitive differentiation is achieved through technology, service model, and channel strength, with some companies focusing on premium pricing and others on cost advantages. However, companies face challenges such as margin pressure, compliance costs, and commoditization, which can impact their ability to invest in R&D and innovation. The following companies are notable players in this market:

GE Healthcare: regional expansion

Siemens Healthcare: innovation pipeline

Philips Healthcare: premium pricing

Advanced Medical: OEM tie-ups

Agfa Healthcare: local manufacturing

Carestream Health: vertical integration

Key Medical Imaging Technologies for Oncology Diagnostics Companies8 items

GE Healthcare

Siemens Healthcare

Philips Healthcare

Advanced Medical

Agfa Healthcare

Carestream Health

McKesson

Techniscan Medical

Market Ecosystem

The Medical Imaging Technologies for Oncology Diagnostics ecosystem encompasses a broad range of participants, from upstream technology providers and suppliers to downstream end users. This ecosystem can be divided into three main segments: upstream, midstream, and downstream. Upstream participants, such as raw material and component suppliers, provide the foundational elements for medical imaging technologies. Midstream participants, including OEMs and system integrators, develop and assemble the technologies. Downstream participants, comprising distributors, service providers, and end users, facilitate the delivery and utilization of these technologies.

Raw material/component suppliers — provide essential components

OEMs / manufacturers — design and produce medical imaging equipment

Technology providers — develop software and algorithms for image analysis

System integrators / EPCs — integrate technologies into comprehensive solutions

Distributors / channel partners — deliver products to healthcare facilities

Service providers / after-sales — offer maintenance, training, and support

End users / buyers — utilize medical imaging technologies for oncology diagnostics

Within the Medical Imaging Technologies for Oncology Diagnostics ecosystem, value flows through the interactions and relationships among participants. Control points, such as regulatory approvals and standards, influence the adoption of these technologies. Dependency risks, including input constraints and interoperability requirements, can impact the ecosystem's functioning. Furthermore, switching costs and partnerships between participants can affect the overall efficiency of the ecosystem. As the ecosystem differs by region, due to varying regulatory frameworks and healthcare infrastructure, a comprehensive value chain analysis is necessary to understand these dynamics and identify opportunities for growth and improvement.

Recent Industry Insights

The Medical Imaging Technologies for Oncology Diagnostics industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between leading healthcare companies and medical technology firms, have enabled the development of innovative solutions. Additionally, mergers and acquisitions have led to the expansion of product portfolios and enhanced market presence. Notable product launches include advanced imaging modalities and artificial intelligence-based diagnostic tools. Furthermore, regulatory changes have facilitated the adoption of medical imaging technologies, while shifts in consumer trends have emphasized the importance of personalized medicine.

The industry has also seen significant funding rounds and expansions, with venture capital firms investing heavily in medical imaging startups. These developments are expected to drive growth in the Medical Imaging Technologies for Oncology Diagnostics industry, enabling the creation of more effective diagnostic solutions and improving patient outcomes. As the industry continues to evolve, it is likely that we will see further innovations and advancements in medical imaging technologies, ultimately shaping the future of oncology diagnostics.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Medical Imaging Technologies for Oncology Diagnostics market outlook. The market attractiveness is high due to the increasing prevalence of cancer and the need for early diagnosis. The competitive intensity is moderate, with key players investing in research and development to improve imaging technologies.

The long-term outlook for the Medical Imaging Technologies for Oncology Diagnostics market is promising, driven by advancements in artificial intelligence and machine learning. The innovation landscape is characterized by the development of new imaging modalities, such as hybrid imaging. However, the demand-supply balance is a key risk factor, as the shortage of skilled professionals and high equipment costs may hinder market growth.

11 items

1. Executive Summary

2. Medical Imaging Technologies for Oncology Diagnostics Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Medical Imaging Technologies for Oncology Diagnostics Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Medical Imaging Technologies for Oncology Diagnostics Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Doctor's Offices

6.1.3. Freestanding Clinics

6.1.4. Equipment Leasing Companies

6.1.5. Other

6.2. Global Medical Imaging Technologies for Oncology Diagnostics Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. X-Ray

6.2.2. Magnetic Resonance Imaging (MRI)

6.2.3. Nuclear Imaging

6.2.4. Other

6.3. Global Medical Imaging Technologies for Oncology Diagnostics Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Medical Imaging Technologies for Oncology Diagnostics Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Medical Imaging Technologies for Oncology Diagnostics Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Medical Imaging Technologies for Oncology Diagnostics Market Competition by Key Manufacturers

8.1. Global Medical Imaging Technologies for Oncology Diagnostics Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Medical Imaging Technologies for Oncology Diagnostics: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. GE Healthcare

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Siemens Healthcare

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Philips Healthcare

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Advanced Medical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Agfa Healthcare

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Carestream Health

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. McKesson

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Techniscan Medical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Medical Imaging Technologies for Oncology Diagnostics Market

Figure 4: Global Medical Imaging Technologies for Oncology Diagnostics Market: Drivers

Figure 5: Global Medical Imaging Technologies for Oncology Diagnostics Market: Challenges

Figure 6: Global Medical Imaging Technologies for Oncology Diagnostics Market: Trends

Figure 7: Global Medical Imaging Technologies for Oncology Diagnostics Market: Opportunity

Figure 8: Global Medical Imaging Technologies for Oncology Diagnostics Market: Restraint

Figure 9: Global Medical Imaging Technologies for Oncology Diagnostics Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Medical Imaging Technologies for Oncology Diagnostics Market Value (USD Million) By Region

Figure 15: Global Medical Imaging Technologies for Oncology Diagnostics Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Medical Imaging Technologies for Oncology Diagnostics Market Value (USD Million) By Region

Figure 23: Global Medical Imaging Technologies for Oncology Diagnostics Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

69 items

Table 1: Market Segmentation Analysis

Table 2: Global Medical Imaging Technologies for Oncology Diagnostics Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Medical Imaging Technologies for Oncology Diagnostics Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Medical Imaging Technologies for Oncology Diagnostics Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Medical Imaging Technologies for Oncology Diagnostics Market Value (USD Million) By Region

Table 10: Global Medical Imaging Technologies for Oncology Diagnostics Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Medical Imaging Technologies for Oncology Diagnostics Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Medical Imaging Technologies for Oncology Diagnostics Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Medical Imaging Technologies for Oncology Diagnostics Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: GE Healthcare Basic Information And Sales Area

Table 31: GE Healthcare. Products Portfolio

Table 32: Siemens Healthcare Basic Information And Sales Area

Table 33: Siemens Healthcare. Products Portfolio

Table 34: Philips Healthcare Basic Information And Sales Area

Table 35: Philips Healthcare. Products Portfolio

Table 36: Advanced Medical Basic Information And Sales Area

Table 37: Advanced Medical. Products Portfolio

Table 38: Agfa Healthcare Basic Information And Sales Area

Table 39: Agfa Healthcare. Products Portfolio

Table 40: Carestream Health Basic Information And Sales Area

Table 41: Carestream Health. Products Portfolio

Table 42: McKesson Basic Information And Sales Area

Table 43: McKesson. Products Portfolio

Table 44: Techniscan Medical Basic Information And Sales Area

Table 45: Techniscan Medical. Products Portfolio

Table 46: Global Market Value (USD Million) (2025-2032) By Application

Table 47: Global Market Share (%) By Application (2032)

Table 48: Global Market Value (USD Million) (2025-2032) By Types

Table 49: Global Market Share (%) By Types (2032)

Table 50: Global Medical Imaging Technologies for Oncology Diagnostics Market Value (USD Million) By Region

Table 51: Global Medical Imaging Technologies for Oncology Diagnostics Market Share (%) By Region (2025-2032)

Table 52: North America Market Value (USD Million) (2025-2032) By Country

Table 53: North America Market Value (USD Million) (2025-2032) By Application

Table 54: North America Market Value (USD Million) (2025-2032) By Types

Table 55: Europe Market Value (USD Million) (2025-2032) By Country

Table 56: Europe Market Value (USD Million) (2025-2032) By Application

Table 57: Europe Market Value (USD Million) (2025-2032) By Types

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 59: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 61: South America Market Value (USD Million) (2025-2032) By Country

Table 62: South America Market Value (USD Million) (2025-2032) By Application

Table 63: South America Market Value (USD Million) (2025-2032) By Types

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 65: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 67: Research Programs/Design For This Report

Table 68: Key Data Information From Secondary Sources

Table 69: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Medical Imaging Technologies for Oncology Diagnostics Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	2.68 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare; Siemens Healthcare; Philips Healthcare; Advanced Medical; Agfa Healthcare; Carestream Health; McKesson; Techniscan Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options